To unblind or not to unblind? That is the question about clinical trials of COVID-19 vaccines
Science-Based Medicine,
Antivaccine alternative health tycoon Joe Mercola claims that the unblinding of participants in the clinical trials of Moderna…
Randomized Double-Blind Phase II Study of Maintenance Pembrolizumab Versus Placebo After First-Line Chemotherapy in Patients With Metastatic Urothelial Cancer.
Overview of attention for article published in Journal of Clinical Oncology, April 2020
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (98th percentile)
-
High Attention Score compared to outputs of the same age and source (98th percentile)
Readers on
- mendeley
- 123 Mendeley